ReportWire

Tag: Health Sciences

  • Breast Cancer Awareness 2025: Share your stories, join our campaign

    [ad_1]

    North of Boston Media Group is preparing to launch its 14th annual Breast Cancer Awareness campaign.

    And we want to share your stories surrounding this far-reaching disease.


    This page requires Javascript.

    Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

    kAm~FC DA64:2= qC62DE r2?46C pH2C6?6DD DFAA=6>6?E 5F6 @FE @? ~4E] `d H:== 9:89=:89E DE@C:6D @7 DFCG:G2=[ 4@FC286[ 56E6C>:?2E:@? 2?5 9@A6]k^Am

    kAmx? 255:E:@?[ :E H:== =@@< 2E E96 C@=6 @7 42C68:G6CD[ @FC =@42= >65:42= 4@>>F?:EJ[ C6D@FC46 286?4:6D 2?5 DFAA@CE ?6EH@CA=6I 5:D62D6 24C@DD @FC }@CE9 @7 q@DE@? 4@>>F?:E:6D]k^Am

    kAms@ J@F 92G6 2 A6CD@?2= DE@CJ E@ D92C6 @C @H D@>6@?6 H9@ 92D H2865 2 4@FC286@FD 32EE=6 282:?DE 3C62DE 42?46Cn s@ J@F @H @7 :?5:G:5F2=D[ @C82?:K2E:@?D @C 286?4:6D E92E 92G6 DE6AA65 FA E@ DFAA@CE A2E:6?ED 2?5 E96:C 72>:=:6D 2D E96J ?2G:82E6 E9C@F89 E96 492==6?86D @7 E96 5:D62D6nk^Am

    kAm(6 9@A6 E@ D9@H42D6 E96D6 DE@C:6D 2?5 >@C6 😕 @FC 2??F2= C6A@CE 2?5[ 😕 5@:?8 D@[ :?DA:C6[ 65F42E6 2?5 C2:D6 2H2C6?6DD 23@FE E96 “!@H6C @7 !:?<” 2?5 E96 @?8@:?8 4@>>:E>6?E E@ E96 7:89E 7@C 2 4FC6]k^Am

    kAm$6?5 J@FC :562D E@ p?? #6:=J 2E k2 9C67lQ>2:=E@i2C6:=Jo?@CE9@73@DE@?]4@>Qm2C6:=Jo?@CE9@73@DE@?]4@>k^2m] %96 5625=:?6 😀 $6AE] `h]k^Am

    [ad_2]

    Source link

  • Care Dimensions celebrates 20 years of compassionate care at Kaplan House

    [ad_1]

    DANVERS — Care Dimensions, the largest hospice and palliative care provider in Massachusetts, recently celebrated the 20th anniversary of the Kaplan Family Hospice House at a special gala event.

    The event, held June 12 at Kernwood Country Club in Salem, brought together community supporters, staff, and volunteers to honor two decades of compassionate end-of-life care at the first-of-its-kind facility in Massachusetts.


    This page requires Javascript.

    Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

    kAm%96 82=2 C2:D65 Sa`c[___ E@ DFAA@CE E96 z2A=2? u2>:=J w@DA:46 w@FD6[ H9:49 92D D6CG65 E9@FD2?5D @7 72>:=:6D D:?46 @A6?:?8 :ED 5@@CD 😕 a__d] %96 7F?5D H:== 5:C64E=J DFAA@CE A2E:6?E 42C6 D6CG:46D 2?5 4@?E:?F6 E96 724:=:EJ’D >:DD:@? @7 AC@G:5:?8 4@>7@CE[ 5:8?:EJ[ 2?5 DA64:2=:K65 42C6 5FC:?8 =:76’D >@DE 492==6?8:?8 >@>6?ED]k^Am

    kAm“tG6?ED =:<6 E@?:89E C6>:?5 FD @7 E96 :?4C65:3=6 86?6C@D:EJ 2?5 4@>A2DD:@? @7 @FC 4@>>F?:EJ[” D2:5 w62E96C y@9?DE@?[ ‘:46 !C6D:56?E 2?5 r9:67 s6G6=@A>6?E ~77:46C 2E r2C6 s:>6?D:@?D] “%96 DFAA@CE H6 C646:G65 E9:D 6G6?:?8 H:== 96=A 6?DFC6 E92E E96 z2A=2? w@FD6 C6>2:?D 2 H2C>[ H6=4@>:?8[ 2?5 H6==>2:?E2:?65 9@>6 7@C 9@DA:46 42C6 7@C E96 ?6IE a_ J62CD 2?5 36J@?5] (6 2C6 566A=J 8C2E67F= E@ 6G6CJ@?6 H9@ ;@:?65 FD 😕 46=63C2E:?8 E9:D >:=6DE@?6]”k^Am

    kAm%96 6G6?:?8 762EFC65 E6DE:>@?:2=D 7C@> 72>:=:6D H9@ 92G6 366? D6CG65 3J E96 z2A=2? u2>:=J w@DA:46 w@FD6[ 9:89=:89E:?8 E96 :>A24E @7 9@DA:46 42C6 @? 3@E9 A2E:6?ED 2?5 E96:C =@G65 @?6D] %96 82=2 2=D@ 9@?@C65 EH@ :?5:G:5F2=D H9@D6 G:D:@? 2?5 =6256CD9:A H6C6 :?DECF>6?E2= 😕 >2<:?8 E96 9@FD6 2 C62=:EJi u@C>6C !C6D:56?E U2>Aj rt~ s:2?6 $EC:?86C 2?5 7@C>6C q@2C5 @7 s:C64E@CD >6>36C %@> u@C5]k^Am

    kAm“%H6?EJ J62CD 28@[ @FC =6256CD 6?G:D:@?65 2 A=246 H96C6 72>:=:6D 4@F=5 7:?5 A6246 2?5 4@>7@CE 5FC:?8 D@>6 @7 E96 >@DE 5:77:4F=E E:>6D @7 E96:C =:G6D[” D2:5 sC] $E6A92?:6 !2E6=[ |s[ !C6D:56?E 2?5 rt~ @7 r2C6 s:>6?D:@?D] “pE E9:D 6G6?E[ H6 46=63C2E65 ?@E ;FDE E96 >:=6DE@?6 @7 EH@ 564256D[ 3FE E96 4@F?E=6DD 72>:=:6D H9@ 92G6 7@F?5 D@=246[ DFAA@CE[ 2?5 5:8?:EJ 2E E96 z2A=2? w@FD6] %9:D 2??:G6CD2CJ C6>:?5D FD H9J E9:D H@C< >2EE6CD D@ 566A=J]”k^Am

    kAm%96 z2A=2? u2>:=J w@DA:46 w@FD6 😀 @?6 @7 EH@ :?A2E:6?E 9@DA:46 724:=:E:6D @A6C2E65 3J r2C6 s:>6?D:@?D[ 2=@?8 H:E9 E96 r2C6 s:>6?D:@?D w@DA:46 w@FD6 😕 {:?4@=?[ H9:49 @A6?65 😕 a_`g] %@86E96C[ E96D6 724:=:E:6D AC@G:56 DA64:2=:K65 9@DA:46 42C6 😕 2 4@>7@CE23=6[ 9@>6=:<6 6?G:C@?>6?E 7@C 9F?5C65D @7 A2E:6?ED 2?5 72>:=:6D 6249 J62C]k^Am

    [ad_2]

    By News Staff

    Source link

  • Lawmaker hosts naloxone training at Statehouse

    [ad_1]

    BOSTON — Rep. Kate Donaghue has a trick for always ensuring naloxone is on hand and ready to deploy if she encounters someone experiencing an opioid overdose: she keeps a dose tucked into the laminated pouch holding her Statehouse ID.

    Donaghue, whose son, Brian, died in 2018 to an overdose, on Tuesday hosted dozens of her colleagues, administration officials, public health workers and others for a training session about how and when to use naloxone.


    This page requires Javascript.

    Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

    kAmpEE6?566D A:=65 :?E@ E96 $E2E69@FD6’D vC62E w2==[ H96C6 @?6 E23=6 H2D 7:==65 H:E9 AC6A24<2865 }2C42? <:ED[ E@ =62C? >@C6 23@FE E96 @A:@:5 6A:56>:4 2?5 E96 C@=6 E92E E96 @G6C5@D6C6G6CD2= 5CF8 A=2JD 😕 <66A:?8 A6@A=6 2=:G6]k^Am

    kAm!C@G:D:@?2= 52E2 7C@> E96 &]$] r6?E6CD 7@C s:D62D6 r@?EC@= 6DE:>2E6 2 ?62C=J bbT 5C@A 😕 AC65:4E65 @G6C5@D6 562E9D 😕 |2DD249FD6EED 7C@> a_ab E@ a_ac[ 2?5 s@?289F6 2EEC:3FE65 >F49 @7 E96 :>AC@G6>6?E E@ E96 2G2:=23:=:EJ @7 ?2=@I@?6[ @7E6? @H? 3J E96 3C2?5 ?2>6 }2C42?]k^Am

    kAm“(96? }2C42? H2D 7:CDE 2G2:=23=6[ H6 H6C6 H@C<:?8 @? 86EE:?8 :E :?E@ E96 92?5D @7 7:CDE C6DA@?56CD 2?5 A6@A=6 :?E6C24E:?8 H:E9 E9@D6 2E 9:89 C:D< @7 @G6C5@D6[” s@?289F6 D2:5] “}@H[ H6 ECJ E@ 86E }2C42? :?E@ E96 92?5D @7 6G6CJ@?6 H9@ 😀 H:==:?8 E@ 42CCJ E9:D =:76D2G:?8 >65:42E:@?]”k^Am

    kAm$E6A96? |FCC2J[ E96 2DD@4:2E6 5:C64E@C @7 @G6C5@D6 AC6G6?E:@? 2E q@DE@? |65:42= r6?E6C 2?5 AC@8C2> 5:C64E@C @7 E96 $276$A@E ~G6C5@D6 w@E=:?6[ C2? E96 EC2:?:?8 27E6C 2? 6IE6?565 DA62<:?8 AC@8C2> 762EFC:?8 @E96C @77:4:2=D 2?5 AC@G:56CD]k^Am

    kAm“(6 ?665 E@ 46=63C2E6 A6@A=6 H9@ 92G6 C64@G6C65] (6 ?665 E@ 96=A A6@A=6 2=@?8 E96 H2J H96? C6=2AD6 😀 A2CE @7 E9:D ;@FC?6J] p?5 H6 92G6 E@ C6>:?5 @FCD6=G6D E92E ?@3@5J C64@G6CD :7 E96J’C6 ?@E 96C6[” w62=E9 2?5 wF>2? $6CG:46D $64C6E2CJ z2E6 (2=D9 D2:5] “}2C42? 😀 C62==J 7F?52>6?E2= E@ @FC 23:=:EJ E@ >2<6 DFC6 E92E A6@A=6 2C6 96C6 E@ 6IA6C:6?46 E96 ;@JD 2?5 H@?56CD 2?5 EC:2=D 2?5 EC:3F=2E:@?D @7 C64@G6CJ]”k^Am

    kAm%96 5CF8 😀 2G2:=23=6 @G6C E96 4@F?E6C 😕 2== d_ DE2E6D] %96 |2DD] s6A2CE>6?E @7 !F3=:4 w62=E9 Ws!wX 92D :DDF65 2 DE2E6H:56 DE2?5:?8 @C56C E92E 2==@HD C6E2:= A92C>24:6D E@ 5:DA6?D6 ?2=@I@?6 H:E9@FE 2 AC6D4C:AE:@?]k^Am

    kAmx? }6H w2>AD9:C6[ E96 =:76D2G:?8 >65:42E:@? 😀 2G2:=23=6 E9C66 H2JDi %96 AF3=:4 42? 86E ?2=@I@?6 2E 2?J @7 E96 ?:?6 s@@CH2JD C64@G6CJ 46?E6CDj 2 A2E:6?E 42? 2D< 9:D @C 96C 5@4E@C E@ HC:E6 2 AC6D4C:AE:@?[ 2?5 E96 >65:42E:@? 😀 2G2:=23=6 H:E9@FE 2 AC6D4C:AE:@? 2E >2?J A92C>24:6D E9C@F89@FE E96 DE2E6]k^Am

    [ad_2]

    By Chris Lisinski | State House News Service

    Source link

  • Rockport school board updated on opioid prevention

    [ad_1]

    The Rockport School Committee, along with the town’s Public Health Department, is aiming to eliminate the effects of possible substance abuse in Rockport schools.

    During the committee’s meeting on June 4, members heard from Dr. Ray Cahill, director of the Rockport Public Health Department, who updated those gathered about the “RIZE Mosaic Opioid Recovery Partnership Grant.” The grant aims to support children and families affected by the opioid crisis.


    This page requires Javascript.

    Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

    kAm%96 8C2?E AC@8C2> 😀 2 ?6H :?:E:2E:G6 7@4FD65 @? 96=A:?8 E9@D6 724:?8 @A:@:5 255:E:@? AC@3=6>D[ r29:== D2:5]k^Am

    kAm“|F?:4:A2=:E:6D 24C@DD E96 4@>>@?H62=E9 92G6 366? 23=6 E@ 2AA=J 7@C @?6J62C >2E49:?8 8C2?ED[” 96 D2:5[ 255:?8 E92E A2CE @7 E96 :?:E:2E:G6 DEC:G6D E@ C65F46 E96 DE:8>2D 2DD@4:2E65 H:E9 @A:@:5 23FD6 2?5 7@DE6C 2 >@C6 DFAA@CE:G6 2?5 :?7@C>65 6?G:C@?>6?E C6=2E65 E@ “@A:@:5 FD6 5:D@C56C]”k^Am

    kAm“%96 E9C66 4@>>F?:E:6D A@@=65 S`d_[___ 2?5 E92E H2D >2E4965[” 96 D2:5] “$@[ E96 E@E2= 8C2?E 😀 Sb__[___]”k^Am

    kAm%96 8C2?E 😀 >2?2865 3J E96 #x+t |2DD249FD6EED u@F?52E:@?[ 2 q@DE@? ?@?AC@7:E 565:42E65 E@ 7F?5:?8 2?5 4C62E:?8 D@=FE:@?D E@ 6?5 E96 @G6C5@D6 4C:D:D 😕 |2DD249FD6EED]k^Am

    kAm“%96 @G6C2C49:?8 8@2= @7 E9:D :?:E:2E:G6 😀 H6 2C6 H@C<:?8 E@ 56G6=@A 2? 64@DJDE6> H96C6 H6 42? C65F46 32CC:6CD E92E :?5:G:5F2=D 7246 H96? E96J’C6 D66<:?8 EC62E>6?E 2?5 C64@G6CJ D6CG:46D[” r29:== D2:5]k^Am

    kAmp 4@>>F?:EJ DFCG6J H2D C646?E=J 4@?5F4E65 @? r2A6 p??[ 96 D2:5[ H9:49 :?5:42E65 E96 7@==@H:?8 E@A 32CC:6CD E@ DF3DE2?46 23FD6 C64@G6CJ AC@8C2>Dik^Am

    kAm %96 4@DE @7 D@36C =:G:?8 AC@8C2>Dk^Am

    kAm %96 4@DE @7 AC6D4C:AE:@? 5CF8D FD65 😕 EC62E>6?Ek^Am

    kAm p446DD 2?5 4@DE C6=2E65 E@ EC2?DA@CE2E:@? E@ >65:42= 2AA@:?E>6?ED 2?5 >65:42= 724:=:E:6Dk^Am

    kAm $E:8>2D C6=2E65 E@ @A:@:5 FD6 5:D@C56Ck^Am

    kAm“xE H2D G6CJ 4=62C H92E E96 E@A 92?57F= @7 32CC:6CD H6C6[” r29:== D2:5]k^Am

    kAm!2CE @7 E96 677@CE ?@H H:== :?4=F56 2 4@>>F?:EJ @FEC6249 AC@46DD E@ D92C6 :?7@C>2E:@? 23@FE E96 8C2?E AC@8C2> E9C@F89@FE E96 4@>>F?:EJ[ 96 D2:5]k^Am

    kAmr29:== 5:5 A@:?E @FE E92E E96 :?:E:2E:G6 😀 ?@E D66? 2D 2 A2?2462 7@C 2== AC@3=6>D C6=2E65 E@ DF3DE2?46 23FD6]k^Am

    kAm“%96C6’D ?@E 2 @?6D:K67:ED2== D@=FE:@? H96? :E 4@>6D E@ 255:4E:@?[” 96 D2:5] “%96C6’D 2 3C@25 DA64ECF> @7 ?665D] x7 H6’C6 8@:?8 E@ 92G6 2 D:8?:7:42?E :>A24E[ H6 ?665 E@ 36 E2=<:?8 23@FE E9:D 2?5 H6 ?665 E@ 36 A@@=:?8 @FC C6D@FC46D 2?5 A@@=:?8 @FC E9@F89ED]k^Am

    kAm“xE’D C62==J E96 @?=J A2E9 E@ 4@>:?8 FA H:E9 4@?DECF4E:G6 @AA@CEF?:E:6D 7@C :?E6CG6?E:@?] z66A:?8 J@FE9 D276 😀 A2C2>@F?E]”k^Am

    kAmk6>m$E6A96? w282? 42? 36 C624965 2E hfgefdaf_g @C 2E k2 9C67lQ>2:=E@iD9282?o8=@F46DE6CE:>6D]4@>QmD9282?o8=@F46DE6CE:>6D]4@>k^2m]k^6>mk^Am

    [ad_2]

    By Stephen Hagan | Staff Writer

    Source link

  • Data: Fewer opioids prescribed in Mass., NH

    Data: Fewer opioids prescribed in Mass., NH

    [ad_1]

    BOSTON — While the scourge of opioid addiction continues to affect Massachusetts, the number of people getting legal prescriptions for heavily addictive medicines is falling, according to the latest federal data.

    Massachusetts had the second lowest opioid prescription rate in New England in 2022, following Vermont, the U.S. Centers for Disease Control and Prevention reported. Health care providers in the Bay State wrote 30.8 opioid prescriptions for every 100 residents, the federal agency reported.

    That’s a slight drop from the previous year but a substantial decline from the 66 per 100 prescription rate in 2006, when the CDC began tracking the data, which lags by two years.

    New Hampshire, which has also seen declining numbers of opioid prescriptions in recent years, had the third-lowest rate in New England in 2022, with 32 prescriptions for every 100 residents. Maine had the highest rate in the region, or 35.2 per 100 residents.

    Nationally, the overall prescription rate was 39.5 prescriptions per 100 people in 2022, according to the CDC data.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years, with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    For many, opioid addiction has its roots in prescription painkillers such as Oxycontin and Percocet, which led them to street-bought heroin and fentanyl once those prescriptions ran out.

    In 2016, then-Gov. Charlie Baker and lawmakers pushed through a raft of rules to curb over-prescribing of opioids. Those included a cap on new prescriptions written in any seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an additive opioid.

    Meanwhile opioid manufacturers have been hammered with hundreds of lawsuits from the states and local governments over their role in fueling a wave of opioid addiction. Attorney General Maura Healey’s office recently agreed to a multi-billion dollar settlement with OxyContin maker Purdue Pharma.

    Supporters of the tougher requirements say they have saved lives by dramatically reducing the number of heavily addictive opioids being prescribed.

    Pain management groups say the regulatory backlash has made some doctors worried about writing prescriptions for opioids, depriving patients of treatment.

    There were 2,125 confirmed or suspected opioid-related deaths in 2023 — which is 10%, or 232, fewer fatal overdoses than the same period in 2022, according to the latest data from the state Department of Public Health.

    Last year’s opioid-related overdose death rate also decreased by 10% to 30.2 per 100,000 people compared with 33.5 in 2022, DPH said.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl. Fentanyl was present in 90% of the overdose deaths where a toxicology report was available, state officials noted.

    Nationally, there were 107,543 overdose deaths reported in the U.S. in 2023, a 3% decrease from the estimated 111,029 in 2022, according to CDC data.

    On Beacon Hill, state lawmakers are being pressured to take more aggressive steps to expand treatment and prevention options for those struggling with opioid addiction.

    Last month, a coalition of more than 100 public health and community-based organizations wrote to House and Senate leaders urging them to pass substance abuse legislation before the Dec. 31 end of the two-year session.

    “There isn’t a day that goes by without several people in the Commonwealth dying from an overdose or losing loved ones to this disease,” they wrote. “As individuals and institutions working to combat the opioid epidemic, we know the Commonwealth must do more to prevent addiction, help people find pathways to treatment and recovery, and save lives.”

    Christian M. Wade covers the Massachusetts Statehouse for North of Boston Media Group’s newspapers and websites. Email him at cwade@cnhinews.com.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Data: Fewer opioids prescribed in Massachusetts

    Data: Fewer opioids prescribed in Massachusetts

    [ad_1]

    BOSTON — While the scourge of opioid addiction continues to affect Massachusetts, the number of people getting legal prescriptions for heavily addictive medicines is falling, according to the latest federal data.

    Massachusetts had the second lowest opioid prescription rate in New England in 2022, following Vermont, the U.S. Centers for Disease Control and Prevention reported. Health care providers in the Bay State wrote 30.8 opioid prescriptions for every 100 residents, the federal agency reported.

    That’s a slight drop from the previous year but a substantial decline from the 66 per 100 prescription rate in 2006, when the CDC began tracking the data, which lags by two years.

    New Hampshire, which has also seen declining numbers of opioid prescriptions in recent years, had the third-lowest rate in New England in 2022, with 32 prescriptions for every 100 residents. Maine had the highest rate in the region, or 35.2 per 100 residents.

    Nationally, the overall prescription rate was 39.5 prescriptions per 100 people in 2022, according to the CDC data.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years, with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    For many, opioid addiction has its roots in prescription painkillers such as Oxycontin and Percocet, which led them to street-bought heroin and fentanyl once those prescriptions ran out.

    In 2016, then-Gov. Charlie Baker and lawmakers pushed through a raft of rules to curb over-prescribing of opioids. Those included a cap on new prescriptions written in any seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an additive opioid.

    Meanwhile opioid manufacturers have been hammered with hundreds of lawsuits from the states and local governments over their role in fueling a wave of opioid addiction. Attorney General Maura Healey’s office recently agreed to a multi-billion dollar settlement with OxyContin maker Purdue Pharma.

    Supporters of the tougher requirements say they have saved lives by dramatically reducing the number of heavily addictive opioids being prescribed.

    Pain management groups say the regulatory backlash has made some doctors worried about writing prescriptions for opioids, depriving patients of treatment.

    There were 2,125 confirmed or suspected opioid-related deaths in 2023 — which is 10%, or 232, fewer fatal overdoses than the same period in 2022, according to the latest data from the state Department of Public Health.

    Last year’s opioid-related overdose death rate also decreased by 10% to 30.2 per 100,000 people compared with 33.5 in 2022, DPH said.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl. Fentanyl was present in 90% of the overdose deaths where a toxicology report was available, state officials noted.

    Nationally, there were 107,543 overdose deaths reported in the U.S. in 2023, a 3% decrease from the estimated 111,029 in 2022, according to CDC data.

    On Beacon Hill, state lawmakers are being pressured to take more aggressive steps to expand treatment and prevention options for those struggling with opioid addiction.

    Last month, a coalition of more than 100 public health and community-based organizations wrote to House and Senate leaders urging them to pass substance abuse legislation before the Dec. 31 end of the two-year session.

    ”There isn’t a day that goes by without several people in the Commonwealth dying from an overdose or losing loved ones to this disease,” they wrote. “As individuals and institutions working to combat the opioid epidemic, we know the Commonwealth must do more to prevent addiction, help people find pathways to treatment and recovery, and save lives.”

    Christian M. Wade covers the Massachusetts Statehouse for North of Boston Media Group’s newspapers and websites. Email him at cwade@cnhinews.com.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Annual Talbot Memorial Walk/Run this Sunday

    Annual Talbot Memorial Walk/Run this Sunday

    [ad_1]

    DANVERS — The annual Talbot Memorial Walk/Run is set to step off Sunday for its 14th annual outing in memory of a Danvers couple who both died after battling cancer.

    “In 2011, our community rallied together for the first Lynda J. Talbot Memorial 5K Walk/Run to honor the life of our mom Lynda J. Talbot after her courageous battle with breast cancer,” Stacy (Talbot) Bazylinski said.

    “In 2022, we lost our dad Bruce after his incredibly courageous fight against lung cancer. To honor their memory and contribute to the ongoing fight against cancer, we have established this memorial 5K.”

    In the 13 years since it was established, the Talbot Memorial Fund has supported more than 100 individuals and families battling cancer on the North Shore.

    In addition, scholarships have been given to some 70 deserving Danvers High School seniors in the memory of the Talbots. Lastly, donations have been made to many cancer research organizations.

    Proceeds from this year’s race will, as always, go to the Talbot Memorial Fund to provide financial support to local families battling cancer and to scholarships to Danvers High students.

    “None of this would be possible without the generosity of all our sponsors and participants,” Julie (Talbot) Donnelly said. “Your commitment to this cause, year after year, has truly made a difference in people’s lives, and we wholeheartedly thank you.”

    Bruce and Lynda Talbot were lifelong Danvers residents. They both attended Danvers High School, created lasting relationships, and raised a family in the community.

    Family, friends, and those who would like to join the camaraderie are encouraged to sign up using the online link talbot.racewire.com

    The event begins at 10 a.m. at the Great Oak School, 76 Pickering St., Danvers.

    [ad_2]

    By Buck Anderson | Staff Writer

    Source link

  • Walking for hospice care

    Walking for hospice care

    [ad_1]

    DANVERS — Care Dimensions, the hospice and palliative care provider, stepped off for its 37th annual Walk for Hospice on Sunday morning on the campus of St. John’s Prep in Danvers.

    The event is designed to offer an opportunity to remember and honor loved ones who have died, while also raising funds for Care Dimensions, which is a nonprofit hospice provider serving more than 100 communities across Eastern Massachusetts.

    Funds from the walk support programs like grief support, music therapy, and other services that benefit hospice patients and their families.

    Before the walk got underway, there were activities and refreshments, as well as music and brief remarks. WCVB meteorologist A.J. Burnett again served as the emcee.

    [ad_2]

    By News Staff

    Source link

  • Breast Cancer Awareness 2024: Share your stories, join our campaign

    Breast Cancer Awareness 2024: Share your stories, join our campaign

    [ad_1]

    The Eagle-Tribune is preparing to launch its 13th annual Breast Cancer Awareness campaign.

    And we want to share your stories surrounding this far-reaching disease.

    Our special Breast Cancer Awareness supplement due out in October will highlight stories of survival, courage, determination and hope.

    In addition, it will look at the role of caregivers, our local medical community, resource agencies and support networks that have joined forces to fight this complex disease across our North of Boston communities.

    Do you have a personal story to share or know someone who has waged a courageous battle against breast cancer? Do you know of individuals, organizations or agencies that have stepped up to support patients and their families as they navigate through the challenges of the disease?

    We hope to showcase these stories and more in our annual report and, in doing so, inspire, educate and raise awareness about the “Power of Pink” and the ongoing commitment to the fight for a cure.

    Send your ideas to Ann Reily at areily@northofboston.com. The deadline is Sept. 13.

    [ad_2]

    Source link

  • Walk for Hospice returning next month in Danvers

    Walk for Hospice returning next month in Danvers

    [ad_1]

    DANVERS  —  Care Dimensions, the largest hospice and palliative care provider in Massachusetts, invites the public to attend the 37th annual Walk for Hospice on Sunday, Sept. 29, at 9 a.m. on the campus of St. John’s Prep in Danvers.

    The walk offers an opportunity to remember and honor loved ones who have died, while also raising funds for Care Dimensions, which is a non-profit hospice provider serving more than 100 communities across Eastern Massachusetts.

    “The Walk for Hospice is both a morning of remembrance and a celebration of life,” said Heather Johnston, chief development officer at Care Dimensions. “Most attendees have been personally touched by the compassionate hospice care our organization provides. Every step taken and every dollar raised helps ensure that we can continue offering exceptional care and support to those in need.”

    Funds from the walk support programs like grief support, music therapy, and other services that benefit hospice patients and their families.

    This is a family and dog-friendly event. Before walkers step off, there will be activities and refreshments, as well as music and brief remarks. WCVB meteorologist A.J. Burnett will once again serve as emcee.

    “Care Dimensions does incredibly valuable work that means so much to so many,” Burnett, who has emceed the event since 2020, said. “I am thrilled to continue supporting the annual Walk for Hospice and to help Care Dimensions fulfill their mission of providing meaningful and compassionate end-of-life care for individuals and families.”

    Care Dimensions was founded in 1978 and provides hospice, palliative care, and in-home primary care to over 1,500 patients every day. St. John’s Prep is located at 72 Spring St., Danvers. 

    Learn more and register at: CareDimensions.org/Walk

    [ad_2]

    Source link

  • Peabody woman defies the odds with kidney transplant

    Peabody woman defies the odds with kidney transplant

    [ad_1]

    PEABODY — There was a time when 58-year-old Ruth Fabello might not have been given the life-saving care she recently received.

    Fabello has an intellectual and developmental disability and has received support services since birth. Since 2002, she’s lived in group homes run by Peabody-based social and human services agency Bridgewell, and in 2013, was diagnosed with stage 4 kidney disease.

    That meant spending a decade on dialysis, multiple complications with her health and long visits to the hospital as she waited for a new kidney.

    She finally received the life-saving transplant on Dec. 20. Eight months later, Fabello is doing great and “feeling good,” as she told The Salem News at her group home in South Peabody Thursday afternoon while sitting with Bridgewell’s Kelli Hyland, the organization’s quality assurance director.

    “Historically, people with disabilities, particularly intellectual disabilities, just didn’t get the same medical and health care that everybody else did,” Hyland said.

    “There’s definitely a lot of work being done in education for doctors and nurses to change this… but when originally this all happened — I’m typically a pessimist — didn’t really think that she would ever get a kidney.

    “But Tufts never saw the disability,” she continued.

    Fabello’s medical team at Tufts Medical Center in Boston made sure she was being cared for and got on the list for a deceased donor’s kidney, Hyland said.

    Now she’s back to doing what she loves: spending time with friends during cooking classes and Bingo games at Bridgewell’s day program, taking part in the Special Olympics’ 400- and 800-meter walking events, and coloring while listening to her favorite song, Michael Jackson’s “Beat It,” in the comfort of her home.

    The most impressive part of Fabello’s journey this last decade has been her attitude, Bridgewell spokesperson Molly McKinney said.

    Fabello’s caretakers called her a “heroine” and “superstar,” McKinney said.

    “They all said how amazing [she was] through the whole process and that [she] never complained,” McKinney said.

    Ruthie was only allowed to drink 36 ounces of water a day while on dialysis and couldn’t take part in her usual Special Olympics events. She suffered infections and had to undergo weight-loss surgery before she could receive a new kidney, and experienced blood clots at the site of the fistula used to administer her dialysis.

    “Ruthie was a trooper with everything that she went through up to the transplant surgery,” Hyland said. “The transplant surgery was easy, at that point.”

    Bridgewell had extra staffing on hand to help Fabello while she was undergoing treatment, Hyland said. That way, the other three residents at her group home still received the attention they needed.

    “In an earlier generation, people with [Intellectual and Developmental Disabilities] with serious chronic conditions seldom reached Ruthie’s age,” McKinney said. “In fact, most people with IDD never reached Ruthie’s age.

    “Today, she is thriving as a result of her personal determination, the dedication of the staff around her and reduced stigma surrounding individuals with disabilities.”

    Fabello’s advice for others in her shoes?

    “Keep on going,” she said.

    Contact Caroline Enos at CEnos@northofboston.com

    [ad_2]

    By Caroline Enos | Staff Writer

    Source link

  • West Nile virus detected in Haverhill

    West Nile virus detected in Haverhill

    [ad_1]

    HAVERHILL — The state Department of Public Health has confirmed that mosquitoes collected locally tested positive for West Nile virus.

    The mosquitoes were among those captured at a surveillance site in Haverhill, according to Deborah Ketchen, health agent for nearby Merrimac, and that town’s Board of Health.

    The board urged its residents to take proper precautions and offered tips in a news release issued Thursday night, noting that the town’s risk level for the West Nile virus remained the same.

    It was not noted whether these mosquitoes were among those that tested positive for West Nile virus and Eastern equine encephalitis in Haverhill on July 30.

    Haverhill Mayor Melinda Barrett announced on the city’s website Aug. 2 that spraying for mosquitoes would begin three days later in a northeastern section of the community due to the positive findings.

    Trucks from the Northeast Massachusetts Mosquito Control District were to begin spraying the insecticide Zenivex E4 RTU in an area “bounded by Main Street to Kenzoa Avenue to Amesbury Road to Kenzoa Street to Center Street to Millvale Road to East Broadway to Old Ferry Road to Lincoln Avenue to Water Street then back to Main Street,” the city said.

    Public health surveillance is conduced in the state for both mosquito-borne illnesses. The highest risk for contracting WNV or EEE is from late July to the first fall frost, according to Merrimac health officials.

    Mosquitoes receive WNV and EEE by biting infected birds. People and animals contract these diseases by being bitten by an infected mosquito.

    Most people bitten by mosquitoes carrying WNV will either have no symptoms or very mild symptoms and recover on their own. People over age 50 have the highest risk of becoming seriously ill, the Merrimac officials said. Additional monitoring and testing of mosquitoes in Haverhill was expected.

    Merrimac health officials and Barrett encourage the public to take precautions, including using DEET mosquito repellant, wearing long sleeves and pants, and avoiding outdoor activities from dusk to dawn.

    Residents are also asked to check their property for containers of standing water that could attract mosquitoes. Tightly fitted screens are needed for windows and doors, the officials said.

    More information about WNV and EEE is available by calling the state Department of Public Health recorded information line at 1-866-MASS-WNV (1-866-627-7968), or the DPH Epidemiology Program at 617-983-6800.

    A fact sheet is available at mass.gov/doc/wnv-factsheet-english/download.

    [ad_2]

    Staff Reports

    Source link

  • Merrimac health officials warn about West Nile virus

    Merrimac health officials warn about West Nile virus

    [ad_1]

    MERRIMAC — Town health officials ask residents to take precautions after the discovery of mosquitoes infected with West Nile virus in nearby Haverhill.  

    The insects were among those trapped at a specific mosquito surveillance site, Merrimac Health Agent Deborah Ketchen and the town’s Board of Health announced in a news release Thursday night.  

    The state Department of Public Health later confirmed that the mosquitoes tested positive for the potentially deadly virus, the health officials said.

    The Health Board urged local residents to take proper precautions and offered tips, noting that the town’s risk level for West Nile virus remained the same.

    It was not noted whether these mosquitoes were among those that tested positive for West Nile virus and Eastern equine encephalitis in Haverhill on July 30.

    Last week, Newburyport confirmed a case of West Nile virus in the city and urged its residents to take precautions. None of the cases in either community involve infected humans.

    Haverhill Mayor Melinda Barrett announced on the city’s website Aug. 2 that spraying for mosquitoes would begin three days later in a northeastern section of the community due to the positive findings.

    Trucks from the Northeast Massachusetts Mosquito Control District were to begin spraying the insecticide Zenivex E4 RTU in an area “bounded by Main Street to Kenzoa Avenue to Amesbury Road to Kenzoa Street to Center Street to Millvale Road to East Broadway to Old Ferry Road to Lincoln Avenue to Water Street then back to Main Street,” the city said. 

    Public health surveillance is conduced in the state for both mosquito-borne illnesses. The highest risk for contracting WNV or EEE is from late July to the first fall frost, according to Merrimac officials. 

    Mosquitoes receive WNV and EEE by biting infected birds. People and animals contract these diseases by being bitten by an infected mosquito.

    Most people bitten by mosquitoes carrying WNV will either have no symptoms or very mild symptoms and recover on their own. People over age 50 have the highest risk of becoming seriously ill, the Merrimac officials said. Additional monitoring and testing of mosquitoes in Haverhill was expected.

    Merrimac health officials and Barrett encourage the public to take precautions, including using DEET mosquito repellant, wearing long sleeves and pants, and avoiding outdoor activities from dusk to dawn.

    Residents are also asked to check their property for containers of standing water that could attract mosquitoes. Tightly fitted screens are needed for windows and doors, the officials said.   

    More information about WNV and EEE is available by calling the state Department of Public Health recorded information line at 1-866-MASS-WNV (1-866-627-7968), or the DPH Epidemiology Program at 617-983-6800.

    A fact sheet is available at mass.gov/doc/wnv-factsheet-english/download.

    [ad_2]

    Staff Reports

    Source link

  • Women’s hockey tournament benefits cancer survivors

    Women’s hockey tournament benefits cancer survivors

    [ad_1]

    HAVERHILL — More than 500 women will hit the ice this weekend with a goal of raising money for cancer survivorship services in the Merrimack Valley.

    The annual Cross Check Cancer Women’s Hockey Tournament will take place from Aug. 9 to 11 at the Valley Forums in Haverhill and Lawrence. The cancer survivorship program is designed to help adults transition to a post-cancer life.

    Games will also be played at HockeyTown U.S.A .in Saugus.

    The women’s tournament was founded by Keri Capobianco in 2016. Capobianco started and runs the Women’s Hockey League of Boston, which calls Haverhill, Methuen and Peabody rinks home. The league is a place where women ages 18 to 60-plus of different skill levels can play hockey.

    The tournament is open to all women, who travel from all over New England to participate.

    All proceeds benefit Dana-Farber Cancer Institute’s Adult Survivorship Program, which offers those 21 years old and older access to services that help adult patients find expertise, education and any support they may need.

    Women who’ve survived cancer or are in treatment have participated in the event over the years, Capobianco said.

    She was drawn to supporting the Dana-Farber program because it’s designed to help people get back to their passions after cancer, whether that’s hockey or another activity. It also places an emphasis on nutrition, exercise and women’s health issues.

    The tournament’s creation was led by a grassroots effort by Capobianco and women from the WHL of Boston eight years ago. In 2016, they were happy to raise $5,200, Capobianco said.

    Now, there are 40 teams signed up for the three-day event and funds raised have grown each year since that first tournament. In 2023, the teams raised more than $65,000. To date, they’ve been able to donate $179,000 to the survivorship program.

    “It’s grown dramatically,” Capobianco said.

    “You don’t see that often where 100% of the proceeds goes to Dana Farber,” tournament participant Christine Ray said. “It’s amazing what Keri (Capobianco) has been able to do with this tournament, especially managing 40 teams at three different rinks.”

    Ray, 59, of Bolton, is one of the many women who travels each year to play in the tournament. She’s played in all eight tournaments so far and her team is ready for the next one.

    Ray first learned to skate at age 43 and has been hooked on hockey ever since. But the summer games mean more than lacing up the skates to her.

    “It’s so much more than hockey,” Ray said. “It gives women a chance to get together and reconnect and do some good at the same time.”

    Ray has known Capobianco for several years by playing hockey with her. Ray formed a tournament team in 2016 to support her friend and has watched as the fundraiser grew to hundreds of women bonding over their passion for the sport as a way to help the cancer community.

    “It’s supporting cancer survivors and being able to play hockey and doing something healthy for ourselves at the same time,” Ray said.

    The goal is to surpass last year’s fundraiser and cross the overall $250,000 mark in its ninth year.

    “We’re always trying to outdo ourselves,” Capobianco said. “We want to hit $70,000 this year.”

    The three rinks are sure to be busy as games are set from 9 a.m. to 10 p.m., but Capobianco said she wouldn’t have it any other way.

    The busyness means women are getting involved and doing their part to continue to benefit the mission of the tournament – cross check cancer.

    “Now we are able to connect these women who share the same passion for hockey and do some good in the world at the same time,” Capobianco said. “It’s a fantastic feeling.”

    [ad_2]

    By Angelina Berube | aberube@eagletribune.com

    Source link

  • Salem Pantry and Mass General Brigham partner to offer free walk-in clinics

    Salem Pantry and Mass General Brigham partner to offer free walk-in clinics

    [ad_1]

    The Salem Pantry and Mass General Brigham announced they will be continuing their partnership to bring their “Community Care Van” weekly free health service to the Pantry’s The Market location at 47 Leavitt St. in Salem.

    In an effort to increase access to essential health care services for residents of Salem and neighboring communities, the van serves as a sort of mobile doctor’s office to provide individuals with medical services like blood pressure screenings, diabetes screenings and care, health education, and care kits. No appointment is needed, and the hospital staffers will not ask about immigration status.

    “Our work with Mass General Brigham is an important part of our commitment to creating an overall healthier community,” said Director of Programs and Partnerships Mike Lilley. “It allows us to address both the immediate need for food and the long-term health needs of our neighbors.”

    “Community Care vans extend the front door of our hospital into the neighborhoods we serve, providing place-based care. Our efforts aim not only to deliver clinical care but also to address social risks, such as food insecurity, which significantly impact health. Community partnerships like these at food pantries are essential to the care we strive to deliver,” said Priya Sarin Gupta, MD MPH, medical director, Clinical Community Programs at Mass General Brigham.

    The Salem Pantry, Mass General Brigham, and the Salem Hospital also offer a weekly mobile food pantry at the North Shore Physicians Group Salem location. Mass General Brigham, which has remained a key financial supporter of the Salem Pantry since 2022, has also helped to develop the pantry’s Food is Medicine program and nutritional services to combat food insecurity locally.

    The Market currently hosts an average of 1,350 weekly visits from residents of Salem and surrounding areas, including Lynn, Peabody, and Beverly. The addition of the Community Care Van at this location is hoped to further support the health and well-being of these communities.

    For more information about The Salem Pantry’s services and walk-in clinic hours, visit thesalempantry.org.

    Michael McHugh can be contacted at mmchugh@northofboston.com or at 781-799-5202

    [ad_2]

    By Michael McHugh | Staff Writer

    Source link

  • Opioid deaths drop 10%, but remain high

    Opioid deaths drop 10%, but remain high

    [ad_1]

    BOSTON — The scourge of opioid addiction continues to affect Massachusetts, but new data shows a double-digit decrease in the number of overdose deaths in the past year.

    There were 2,125 confirmed or suspected opioid-related deaths in 2023 — which is 10%, or 232, fewer fatal overdoses than during the same period in 2022, according to a report released this week by the state Department of Public Health.

    Last year’s opioid-related overdose death rate also decreased by 10% to 30.2 per 100,000 people compared to 33.5 in 2022, DPH said.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl.

    Fentanyl was present in 90% of the overdose deaths where a toxicology report was available, state officials noted.

    Preliminary data from the first three months of 2024 showed a continued decline in opioid-related overdose deaths, the agency said, with 507 confirmed and estimated deaths, a 9% drop from the same time period last year.

    Gov. Maura Healey said she is “encouraged” by the drop in fatal overdoses but the state needs to continue to focus on “prevention, treatment and recovery efforts to address the overdose crisis that continues to claim too many lives and devastate too many families in Massachusetts.”

    Substance abuse counselors welcomed the declining number of fatal opioid overdoses, but said the data shows that there is still more work to be done to help people struggling with substance use disorders.

    “While the number of opioid-related overdose deaths in the commonwealth remains unacceptably high, it is encouraging to see what we hope is a reversal of a long and painful trend,” Bridgewell President & CEO Chris Tuttle said in a statement. “The time is now to boost public investments and once and for all overcome the scourge of the opioid epidemic.”

    Nationally, there were 107,543 overdose deaths reported in the U.S. in 2023, a 3% decrease from the estimated 111,029 in 2022, according to recently released U.S. Centers for Disease Control and Prevention data.

    In New Hampshire, drug overdose deaths also declined by double digits in 2023, according to figures released in May by the state’s medical examiner and the National Centers for Disease Control.

    There were 430 deaths attributed to overdoses in 2023, an 11.7% decrease from 2022’s 487, according to the data.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    The state has set some of the strictest opioid-prescribing laws in the nation, including a cap on new prescriptions in a seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an addictive opioid.

    Hundreds of millions of dollars are flowing into the state from multistate settlements with opioid makers and distributors, including $110 million from a $6 billion deal with OxyContin maker Purdue Pharma and the Sackler family.

    Under state law, about 60% of that money will be deposited in the state’s opioid recovery fund, while the remainder will be distributed to communities.

    Earlier this week, House lawmakers were expected to take up a package of bills aimed at improving treatment of substance abuse disorders and reducing opioid overdose deaths.

    The plan would require private insurers to cover emergency opioid overdose-reversing drugs such as naloxone and require drug treatment facilities to provide two doses of overdose-reversal drugs when discharging patients, among other changes.

    Another provision would require licenses for recovery coaches, who are increasingly sent to emergency rooms, drug treatment centers and courtrooms to help addicts get clean.

    Backers of the plan said the goal is to integrate peer recovery coaches more into the state’s health care system, helping addicts who have taken the first steps toward recovery.

    Long-term recovery remains one of the biggest hurdles to breaking the cycle of addiction, they say.

    Christian M. Wade covers the Massachusetts Statehouse for North of Boston Media Group’s newspapers and websites. Email him at cwade@cnhinews.com.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Report: Injured workers at risk for opioid overdoses

    Report: Injured workers at risk for opioid overdoses

    [ad_1]

    Workers who are injured on the job are at higher risk for fatal opioid-related overdoses, according to a new study, which calls for renewed efforts to reduce the stigma of drug addiction.

    The report, released Thursday by the state Department of Public Health, found that working-age Massachusetts residents who died between 2011 and 2020 were 35% more likely to have died of an opioid-related overdose if they had previously been injured at work.

    DPH researchers compiled information about individuals’ employment and work-related injury status from their workers’ compensation claims and linked it with data from their death certificates.

    Researchers reviewed the details of 4,304 working-age adults who died between 2011 and 2020 and found at least 17.2% had at least one workplace injury claim and died of an opioid-related overdose, according to the study.

    Public health officials say the study is the first linking the impact of work-related injuries to opioid-related overdose deaths.

    “Occupational injuries can take both a physical and mental toll, and those who suffer injuries at work may be discouraged from seeking help because of stigmatization and fear of losing their jobs,” Health and Human Services Secretary Kate Walsh said in a prepared statement. “Avoiding or delaying care can lead to a preventable overdose death.”

    She called for stepped-up efforts to “eliminate the stigma that accompanies substance use disorder in all sectors of society, including the workplace.”

    The release of the report comes as opioid overdose deaths remain devastatingly high in the Bay State, despite a slight decrease over the past year.

    There were 2,323 confirmed or suspected opioid-related deaths in Massachusetts from Oct. 1, 2022 to Sept. 30, 2023 — eight fewer than the same period in 2021, according to a report released in December by the health department.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl.

    Fentanyl was present in 93% of the overdose deaths where a toxicology report was available, state officials noted.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    The state has set some of the strictest opioid prescribing laws in the nation, including a cap on new prescriptions in a seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an addictive opioid.

    The Opioid Recovery and Remediation Fund, created by the state Legislature in 2020, has received more than $101 million from settlements with drug makers and distributors over their alleged role in the opioid crisis, according to the Executive Office of Health and Human Services.

    More than 25,000 people have died from opioid-related overdoses in Massachusetts since 2011, according to state records.

    Nationally, fatal drug overdoses fell by roughly 3% in 2023, according data from the U.S. Centers for Disease Control and Prevention.

    But the toll from fatal overdoses in 2023 remained high, claiming 107,543 lives, the federal agency said.

    Fentanyl and other synthetic opioids were responsible for about 70% of lives lost, while methamphetamine and other synthetic stimulants are responsible for about 30% of deaths, the CDC said.

    “The shift from plant-based drugs, like heroin and cocaine, to synthetic, chemical-based drugs, like fentanyl and methamphetamine, has resulted in the most dangerous and deadly drug crisis the United States has ever faced,” Anne Milgram, head of the Drug Enforcement Administration, said in a recent statement.

    The DEA points to Mexican drug cartels, who it says are smuggling large quantities of fentanyl and other synthetic drugs manufactured in China into the country, along the southern border.

    “The suppliers, manufacturers, distributors, and money launderers all play a role in the web of deliberate and calculated treachery orchestrated by these cartels,” she said.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • Report: Injured workers at risk for opioid overdoses

    Report: Injured workers at risk for opioid overdoses

    [ad_1]

    Workers who are injured on the job are at higher risk for fatal opioid-related overdoses, according to a new study, which calls for renewed efforts to reduce the stigma of drug addiction.

    The report, released Thursday by the state Department of Public Health, found that working-age Massachusetts residents who died between 2011 and 2020 were 35% more likely to have died of an opioid-related overdose if they had previously been injured at work.

    DPH researchers compiled information about individuals’ employment and work-related injury status from their workers’ compensation claims and linked it to data from their death certificates.

    Researchers reviewed the details of 4,304 working-age adults who died between 2011 and 2020 and found at least 17.2% had at least one workplace injury claim and died of an opioid-related overdose, according to the study.

    Public health officials say the study is the first linking the impact of work-related injuries to opioid-related overdose deaths.

    “Occupational injuries can take both a physical and mental toll, and those who suffer injuries at work may be discouraged from seeking help because of stigmatization and fear of losing their jobs,” Health and Human Services Secretary Kate Walsh said in a statement. “Avoiding or delaying care can lead to a preventable overdose death.”

    Walsh called for stepped-up efforts to “eliminate the stigma that accompanies substance use disorder in all sectors of society, including the workplace.”

    The release of the report comes as opioid overdose deaths remain devastatingly high in the Bay State, despite a slight decrease over the past year.

    There were 2,323 confirmed or suspected opioid-related deaths in Massachusetts from Oct. 1, 2022, to Sept. 30, 2023 — eight fewer than the same period in 2021, according to a report released in December by the health department.

    Health officials attributed the persistently high death rates to the effects of an “increasingly poisoned drug supply,” primarily with the powerful synthetic opioid fentanyl.

    Fentanyl was present in 93% of the overdose deaths where a toxicology report was available, state officials noted.

    Curbing opioid addiction has been a major focus on Beacon Hill for a number of years with hundreds of millions of dollars being devoted to expanding treatment and prevention efforts.

    The state has set some of the strictest opioid-prescribing laws in the nation, including a cap on new prescriptions in a seven-day period and a requirement that doctors consult a state prescription monitoring database before prescribing an addictive opioid.

    The Opioid Recovery and Remediation Fund, created by the state Legislature in 2020, has received more than $101 million from settlements with drug makers and distributors over their alleged role in the opioid crisis, according to the Executive Office of Health and Human Services.

    More than 25,000 people have died from opioid-related overdoses in Massachusetts since 2011, according to state records.

    Nationally, fatal drug overdoses fell by roughly 3% in 2023, according data from the U.S. Centers for Disease Control and Prevention.

    But the toll from fatal overdoses in 2023 remained high, claiming 107,543 lives, the federal agency said.

    Fentanyl and other synthetic opioids were responsible for approximately 70% of lives lost, while methamphetamine and other synthetic stimulants are responsible for approximately 30% of deaths, the CDC said.

    “The shift from plant-based drugs, like heroin and cocaine, to synthetic, chemical-based drugs, like fentanyl and methamphetamine, has resulted in the most dangerous and deadly drug crisis the United States has ever faced,” Anne Milgram, head of the Drug Enforcement Administration, said in a recent statement.

    The DEA points to Mexican drug cartels, who it says are smuggling large quantities of fentanyl and other synthetic drugs manufactured in China into the country along the southern border.

    “The suppliers, manufacturers, distributors, and money launderers all play a role in the web of deliberate and calculated treachery orchestrated by these cartels,” she said.

    Christian M. Wade covers the Massachusetts Statehouse for North of Boston Media Group’s newspapers and websites. Email him at cwade@cnhinews.com.

    [ad_2]

    By Christian M. Wade | Statehouse Reporter

    Source link

  • About 22 high school age adolescents died each week from overdoses in 2022, driven by fentanyl-laced prescription pills

    About 22 high school age adolescents died each week from overdoses in 2022, driven by fentanyl-laced prescription pills

    [ad_1]

    BYLINE: Enrique Rivero

    EMBARGOED FOR USE UNTIL:

    7:30 A.M. (ET) ON JANUARY 6, 2024

     

    About 22 high school age adolescents died each week from overdoses in 2022, driven by fentanyl-laced prescription pills

    Newswise — An average of 22 adolescents 14 to 18 years of age died in the U.S. each week in 2022 from drug overdoses, raising the death rate for this group to 5.2 per 100,000– driven by fentanyl in counterfeit pills, new research finds.

    Adolescent overdoses had more than doubled among this group between 2019 and 2020, and have since intensified to such an extent that the death count equals a high school classroom each week, and is now the third largest cause of pediatric deaths behind firearm-related injuries and motor vehicle collisions. 

    The increase is, however, not due to more illicit drug use – which has in fact fallen over the years; for example, excluding cannabis, the rate of any illicit drug use among just 12th graders had fallen from about 21% to 8% in the 20 years since 2002. Instead, the increase is the result of drugs becoming deadlier due to fentanyl, which is increasingly found in counterfeit oxycodone, benzodiazepines and other prescription pills that fall into the hands of adolescents.

    But educators, physicians, and mental health practitioners can be instrumental in helping to stem this tide through pointed questions and guidance about drug use and the dangers that counterfeit pills present, the researchers write in a paper published in the New England Journal of Medicine. In addition, policymakers can focus on “hotspot” counties, most in western states, with particularly high overdose deaths.

    “Teenagers are likely to be unaware of just how high-risk experimenting with pills has become, given the recent rise in counterfeit tablets” said study co-author Joseph Friedman, a researcher at UCLA. “It’s often impossible to tell the difference with the naked eye between a real prescription medication obtained from a doctor and a counterfeit version with a potentially deadly dose of fentanyl. It’s urgent that teenagers be given accurate information about the real risks, and strategies to keep themselves and their friends safe.” 

    The researchers found that adolescent overdoses were occurring at double the national average in Arizona, Colorado and Washington State between 2020 and 2022. They identified 19 hotspot counties – that is, those with at least 20 overdose deaths and death rates higher than the national average, with Maricopa County in Arizona and Los Angeles County having the most fatal overdoses at 117 and 111, respectively, during this period. 

    The other 17 counties are Orange County, California (61 deaths), Cook County, Illinois (56), San Bernardino County, California (54), King County, Washington (52), Riverside County, California (41), San Diego County, California (36), Tarrant County, Texas (35), Clark County, Nevada (31), Kern County, California (30), Pima County, Arizona (29), Adams County, Colorado (25), Denver County, Colorado (24), Jackson County, Missouri (24), Santa Clara County, California (24), Bernalillo County, New Mexico (23), Davidson County, Tennessee (21), and Marion County, Indiana (21). 

    In addition, American Indian and Alaska Native adolescents had 1.82 times the overdose rates of whites between 2020 and 2022. And adolescents are overall likelier to use the pill form of the drug rather than powder, which was previously the main fentanyl source. For instance, while 0.3% of high school seniors in 2022 reported using heroin, which comes in powder form, 5% reported nonmedical use of prescription pills the same year.

    The researchers provide the following recommendations to combat these trends:

    • Pediatricians, other primary care physicians, and mental health practitioners should ask their adolescent patients if they or their peers were approached either in person or via social media about buying pills, or if they have used them without prescriptions
    • Educators, along with parents, can discuss with adolescents the dangers associated with counterfeit pills; these efforts should be especially prioritized in hotspot locations
    • Clinicians, educators and parents can highlight the Safety First curriculum that emphasizes abstinence from drugs and provides information about risk reduction for those who do experiment with drugs, such as where to find and how to use the overdose-reversal agent naloxone
    • Finally, naloxone should be available in schools, which should also adopt “no-questions-asked” pill-disposal programs as well as provide anonymous mechanisms such messaging services that students can use to ask about counterfeit pills and substance use without risk of punishment or embarrassment.

    “Fentanyl has rapidly become a leading cause of death in American teens,” said Dr. Scott Hadland, chief of adolescent medicine at Mass General for Children and senior author on the paper. “Policymakers, clinicians, families and communities need to partner together to address this worsening public health threat.”

    [ad_2]

    University of California, Los Angeles (UCLA), Health Sciences

    Source link

  • Antibody-drug conjugate helps patients with metastatic non-small cell lung cancer live longer, delaying disease progression

    Antibody-drug conjugate helps patients with metastatic non-small cell lung cancer live longer, delaying disease progression

    [ad_1]

    BYLINE: Denise Heady

    Newswise — Treatment with datopotamab deruxtecan (Dato-DXd), a novel Trop-2 directed antibody-drug conjugate, was found to significantly improve progression-free survival in patients with metastatic non-small cell lung cancer, an improvement that was primarily driven by patients with non-squamous tumors.

    These results from the TROPION-Lung01 Phase III trial, which compared the standard of care in second-line docetaxel, a type of chemotherapy, with Dato-DXd, an antibody drug conjugate, in patients with pretreated metastatic non-small cell lung cancer, were presented at the European Society for Medical Oncology 2023 Congress by Dr. Aaron Lisberg, assistant professor of medicine and thoracic medical oncologist at the UCLA Health Jonsson Comprehensive Cancer Center and the David Geffen School of Medicine at UCLA.

    Lisberg and the team found that patients treated with Dato-DXd experienced a 25% reduction in the risk of disease progression or death compared to patients treated with docetaxel.

    “While there was an overall reduction of disease progression, the data clearly indicates that this benefit was primarily driven by patients with non-squamous tumors,” Lisberg said.

    More than 75% of enrolled patients had non-squamous tumors, noted Lisberg. And in that group alone, the therapy reduced the risk of disease progression or death by 37%, while patients with squamous tumors did not appear to derive a therapeutic benefit from Dato-DXd on trial.

    In addition, a trend in favor of Dato-DXd was observed in the interim overall survival analysis. In those assessments of how long a patient will live after receiving a therapy for their cancer, the improvement was most pronounced in the non-squamous population with a reduction in the risk of death of 23% with Dato-DXd.

    The improvements in progression-free and overall survival observed in the Dato-DXd treated patients were accompanied by significant tumor shrinkage with Dato-DXd (26.4%) vs docetaxel (12.8%), a difference that was more pronounced in patients with non-squamous tumors (31.2% vs 12.8%).

    The overall safety profile of Dato-DXd was superior to docetaxel as fewer patients had high grade drug related toxicities with Dato-DXd (25%) compared to docetaxel (41%). Common side effects of Dato-DXd included mild to moderate mouth sores and nausea. There were also fewer severe side effects leading to dose reduction or treatment discontinuation in Dato-DXd treated patients compared to those treated with docetaxel.

    “Dato-DXd is the first antibody-drug conjugate in metastatic non-small cell lung cancer to demonstrate a statistically significant improvement in progression-free survival over the standard of care chemotherapy drug docetaxel, while evidencing a more favorable safety profile due to its unique ability to selectively delivers a potent chemotherapy directly into tumor cells,” said Lisberg.

    These findings are encouraging, noted Lisberg, since the current standard of care second-line chemotherapy docetaxel is associated with modest benefit and substantial toxicity and suggest that Dato-DXd has the potential to be new therapy for patients with previously treated non-squamous non-small cell lung cancer.

    TROPION-LUNG01 Study Design

    Researchers on the global TROPION-LUNG01 trial compared the effectiveness and tolerability of Dato-DXd vs docetaxel by randomizing 604 patients to receive either Dato-DXd (299 patients) or docetaxel (305) patients. Patients both with and without genetic driver mutations such as EGFR were enrolled and must have received multiple therapies for metastatic non-small cell lung cancer prior to enrollment. No minimum level of TROP-2 expression on the tumor surface was required for enrollment, as TROP-2 expression has not been found to correlate with Dato-DXd effectiveness, to date.

    UCLA Leadership in Dato-DXd Development

    UCLA’s thoracic medical oncology team has been at the forefront of Dato-DXd’s global development punctuated by Lisberg’s ESMO 2023 TROPION-LUNG01 Presidential Symposium. Critical support has been provided by the Hematology/Oncology Clinical Research Unit, as well as Lisberg’s UCLA thoracic medical oncology colleagues Dr. Edward Garon, Dr. Jonathan Goldman, and Dr. Amy Cummings, who identified the potential of Dato-DXd early on in development and prioritized Dato-DXd for their heavily pretreated non-small cell lung cancer patients. These patients had a paucity of effective treatment options at the time of Dato-DXd trial enrollment and their participation was essential to the success of the TROPION-LUNG01 study, with many experiencing a prolonged improvement in their lives, as result of Dato-DXd. The TRIO-US network also made significant contributions to the TROPION-LUNG01 study under the direction of Lisberg.

    UCLA and TRIO-US Network at Forefront of Future Dato-DXd Lung Cancer Trials

    This antibody-drug conjugate is now being evaluated as potential first-line therapy for patients with newly diagnosed metastatic non-small cell lung cancer on the TROPION-LUNG07/08 studies (NCT05555732/NCT05215340), both of which were recently opened at UCLA clinics throughout Southern California. In addition, the TRIO-US network is participating in the TROPION-LUNG07 trial, as it did for TROPION-LUNG01. These trials hold the promise to improve clinical outcomes for patients with metastatic non-small cell lung cancer by providing Dato-DXd to an even larger number of patients with non-squamous tumors.

    Datopotamab deruxtecan is a specifically engineered TROP2-directed DXd antibody drug conjugate being jointly developed by AstraZeneca and Daiichi Sankyo.

    [ad_2]

    University of California, Los Angeles (UCLA), Health Sciences

    Source link